GLP-1 is the most-asked health topic of 2026. When patients ask AI where to start in India, who gets named?
CiteRank measures who AI engines recommend in glp-1 & metabolic care — across ChatGPT, Gemini and Claude, in both grounded and ungrounded modes — and fixes why it isn't you.
The glp-1 & metabolic care leaderboard, measured.
Top-5 brand mention rate, first-mention rate and Share of Voice — straight from the citerank-bench scoring tables, recomputed weekly.
Benchmark for GLP-1 & Metabolic Care runs with our first founding customer in this vertical. The leaderboard below is an illustrative sample built from the blueprint's brand registry — numbers are placeholders, not measurements.
Illustrative sample — benchmark not yet completed.
Real glp-1 & metabolic care prompts, three engines, one question: did you get cited?
Three failure modes specific to healthcare.
Same-3-clinics lock-in: AI defaults to a handful of names per city and topic.
Trust signals AI looks for (NABH, doctor entities, accreditations) are missing or unstructured on most sites.
Patient-safety framing means a wrong AI answer is a real-world risk, not a ranking nuisance.
How a glp-1 & metabolic care benchmark gets built.
URL, competitors, prompt seed list. 5 minutes.
250+ prompts × 3 engines × 2 modes, 10–30 replays each.
Schema, llms.txt, entity hygiene, content briefs — shipped.
Weekly re-runs, deltas with 95% confidence bands.
What a 90-day citation delta looks like.
Illustrative pattern based on our methodology — first cohort results publish Q4 2026.
Cited in 1 of 25 high-intent glp-1 & metabolic care prompts across 3 engines (4%).
Cited in 9 of the same 25 prompts (36%) — schema, llms.txt and entity fixes shipped over 3 weekly re-runs.
GLP-1 & Metabolic Care case study publishes after the first 90-day window.
We don't ship anonymous success stories. Every case study card on this page becomes a real logo, real prompts and real deltas after the customer's 90-day window closes.
Coming in the GLP-1 & Metabolic Care visibility report.
Safe-pathway citations: how legitimate clinics displace grey-market answers
Notify me when publishedPricing volatility and AI: keeping engines current on GLP-1 costs
Notify me when publishedGLP-1 & Metabolic Care questions, answered.
How is CiteRank different from Practo / 1mg listings?+
Those surfaces optimise for their own funnel. CiteRank measures how often ChatGPT, Gemini and Claude actually name your brand for glp-1 & metabolic care buyer prompts, then fixes the schema, entity and content gaps so the engines have something to cite besides the aggregator.
Which segments / cities do you cover for this vertical?+
We start with your 250+ highest-intent buyer prompts — segmented by city, persona and price band as relevant — and expand the prompt graph weekly. Coverage scope is set during the 5-minute onboarding.
How fast to first new citation?+
First measurable citation lift is typically 3–5 weeks after the first fix pass (schema, llms.txt, entity, content briefs). Re-runs are weekly with 95% confidence bands so you can attribute deltas to specific fixes.
Is our data sent to LLMs?+
Only the public buyer prompts we run on your behalf reach the engines — exactly what a prospective customer would type. We do not send your CRM, customer data, or internal documents to any LLM.
Start with one snapshot. Scale into weekly monitoring.
250+ prompts × 3 engines × 2 modes. Brand-mention report and gap analysis.
Weekly re-runs, deltas with confidence bands, alerting on rank/citation changes.
Monitor + shipped fixes: schema, llms.txt, entity, content briefs and re-measurement.
